Table 1.

Cohort Characteristics by Gender and Screening Use

Parameter	Women		Men
	All	% Receiving mammography screening*	All	% Receiving PSA screening*
No. of patients	543,970	43.9	362,753	25.6
Age (years)
69–74	183,802	53.5	145,427	29.2
75–79	154,554	47.8	107,627	26.2
80–84	121,645	38.1	71,658	21.9
85–89	83,968	23.9	38,041	17.6
Race/ethnicity
White	481,466	45.0	324,619	26.4
Black	40,888	36.3	22,809	16.8
Other	21,615	33.0	15,325	21.9
Medicaid eligibility
No	466,230	46.7	334,294	26.3
Yes	77,739	27.3	28,459	18.2
No. of comorbidities
0	152,303	40.9	121,930	21.0
1–2	146,586	50.5	88,165	31.8
2	109,437	47.2	66,239	29.5
3+	135,643	37.3	86,419	23.0
Predicted life expectancy (years)
<3	24,722	20.3	23,552	15.9
3–4	47,541	26.0	42,229	20.3
5–6	74,254	32.1	58,415	23.2
7–8	80,108	40.3	65,133	26.2
9+	317,344	52.1	173,424	28.9

* Receipt of a screening mammogram was assessed over a 2-year period, 2001–2002, because some authorities recommend every other year screening. Receipt of a screening PSA test was assessed in 2002